By Editor, Global AgInvesting Media Spanish foodtech startup MOA Foodtech has raised €3.3 million ($3.8 million) in a ne…

A protein better known for its role in immune checkpoint signaling may help harmful aging cells, or senescent cells, remain hidden from the immune system, allowing them to accumulate in tissues and contribute to age-related dysfunction, according to a new study from Cedars-Sinai Health Sciences University investigators.

By Editor, Global AgInvesting Media As institutional interest in real assets continues to broaden across Europe and glob…

Since the attacks on the World Trade Center in New York City, at the Pentagon in Arlington, Virginia, and near Shanksville, Pennsylvania on September 11, 2001, scientists and clinicians have learned much about the enduring effects of exposure to environmental toxins and hazardous materials. A perspective paper, published today in JAMA , highlights some insights from long-term follow-up of people with 9/11-related health effects, lessons learned in terms of care delivery and clinical understanding, as well as some implications for future disaster responses. 

As soon as a cancer cell appears, the immune system jumps into action—and interferons (IFNs) are among the first responders. Interferons are pro-inflammatory cytokines, or signaling proteins, that recruit specialized immune cells, such as like T cells or B cells to destroy the cancer. This is a critical, powerful step in the body’s fight against cancer, but chronic exposure to interferons can turn them from ally to enemy.

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more efficient and sustainable.

Teijin, Teijin Regenet, and Shinshu University Hospital, all based in Japan, entered into a joint research agreement regarding manufacturing technologies for cell and gene therapy products. The collaboration aims to advance manufacturing methods and strengthen Japan’s manufacturing infrastructure for cell and gene therapies with the goal of helping to contribute to the  broader availability of these innovative treatments.